Assessment of performance characteristics of COVID-19 ICD-10-CM diagnosis code U07.1 using SARS-CoV-2 nucleic acid amplification test results

The Food and Drug Administration’s Biologics Effectiveness and Safety Initiative conducts active surveillance to protect public health during the coronavirus disease 2019 (COVID-19) pandemic. This study evaluated performance of International Classification of Diseases, Tenth Revision, Clinical Modif...

Descripción completa

Detalles Bibliográficos
Autores principales: Moll, Keran, Hobbi, Shayan, Zhou, Cindy Ke, Fingar, Kathryn, Burrell, Timothy, Hernandez-Medina, Veronica, Obidi, Joyce, Alawar, Nader, Anderson, Steven A., Wong, Hui-Lee, Shoaibi, Azadeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387790/
https://www.ncbi.nlm.nih.gov/pubmed/35980905
http://dx.doi.org/10.1371/journal.pone.0273196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387790/
https://www.ncbi.nlm.nih.gov/pubmed/35980905
http://dx.doi.org/10.1371/journal.pone.0273196

Ejemplares similares